{"gene":"PCLO","run_date":"2026-04-29T11:37:58","timeline":{"discoveries":[{"year":2002,"finding":"PCLO encodes the presynaptic cytoskeletal protein Piccolo, which is a component of presynaptic active zones involved in assembly and function of active zones as sites of neurotransmitter release; comparative sequence analysis identified distinct homology domains shared partially with Bassoon, indicating related but distinct functions at active zones.","method":"cDNA cloning, comparative sequence analysis, chromosomal localization, gene structure characterization across human, mouse, rat, and chicken","journal":"International journal of developmental neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — gene structure and domain architecture established by direct molecular characterization; single lab, multiple species comparison","pmids":["12175852"],"is_preprint":false},{"year":2015,"finding":"The PCLO p.Ser4814Ala (rs2522833) variant, located near a calcium-sensing domain of Piccolo, increases synaptic Piccolo protein levels and produces ~30% increased excitatory synaptic transmission in cultured neurons; calcium-dependent phospholipid binding, synapse formation in vitro, and synaptic vesicle accumulation were unaltered by this variant.","method":"Mouse knock-in model (Pclo SA/SA), electrophysiology in cultured neurons, calcium-dependent phospholipid binding assay, immunostaining for synaptic protein levels","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo knock-in model combined with multiple orthogonal cellular assays (electrophysiology, binding assay, immunostaining)","pmids":["26045179"],"is_preprint":false},{"year":2015,"finding":"Homozygous nonsense mutation in PCLO (predicted to eliminate the PDZ and C2 domains in the C-terminus) causes loss of Piccolo protein function and underlies autosomal recessive pontocerebellar hypoplasia type III (PCH3), establishing that PCLO is essential for development and survival of neuronal types in the human brain.","method":"Whole-exome sequencing, Sanger sequencing, linkage analysis, human fetal brain RNA sequencing","journal":"Neurology","confidence":"Medium","confidence_rationale":"Tier 2 — segregating loss-of-function variant with defined neurological phenotype; single family but supported by domain-level prediction","pmids":["25832664"],"is_preprint":false},{"year":2013,"finding":"The deep intronic SNP rs13438494 in intron 24 of PCLO alters splicing efficiency by creating or disrupting splicing regulatory motifs (enhancer/silencer binding sites), with the C allele reducing splicing efficiency of the PCLO minigene.","method":"Functional minigene splicing assay, bioinformatics prediction of splicing regulatory sequences (Human Splice Finder)","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — direct minigene functional assay demonstrating altered splicing; single lab with functional validation","pmids":["24167553"],"is_preprint":false},{"year":2025,"finding":"Piccolo is expressed as a novel astrocyte-specific isoform that partially localizes at the Golgi apparatus; loss of Piccolo function in astrocytes (Pclo gt/gt rat model) causes fragmented Golgi morphology and impaired secretion of extracellular matrix components Brevican and Tenascin-R, leading to reduced synapse density in co-cultured neurons and altered network activity, deficits rescued by wild-type astrocyte conditioned media.","method":"Pclo gene-trap rat model, RNA-sequencing, immunohistochemistry/immunocytochemistry, GM130 Golgi staining, astrocyte-conditioned media rescue experiments, electrophysiology (mEPSC, mIPSC, RRP), co-culture synapse density assays","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in a genetic model with functional rescue; preprint, not yet peer-reviewed","pmids":["bio_10.1101_2025.07.03.662734"],"is_preprint":true},{"year":2025,"finding":"A novel homozygous missense variant in PCLO (p.Met153Thr) causes PCH3; CRISPR-generated PCLO knockout cell model confirmed loss of Piccolo protein function and showed that Piccolo deficiency affects expression of interacting genes CtBP1 and BSN (Bassoon).","method":"Whole-exome sequencing, CRISPR knockout cell model, real-time PCR, in silico pathogenicity analysis","journal":"Galen medical journal","confidence":"Medium","confidence_rationale":"Tier 2 — CRISPR loss-of-function model with molecular readouts; single lab","pmids":["42038819"],"is_preprint":false},{"year":2025,"finding":"PCLO protein (Piccolo) was identified as an autoimmune antigenic target in sarcoid uveitis: anti-PCLO autoantibodies (humoral response) and PCLO-reactive T-lymphocytes (cellular response) were detected in anti-retinal antibody-positive sarcoid uveitis patients.","method":"HuScan linear epitope autoantibody profiling, bead-based anti-PCLO antibody assay, ELISpot for PCLO-reactive T-lymphocytes, indirect immunofluorescence, TCR/BCR next-generation sequencing","journal":"Journal of autoimmunity","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal immunological assays identifying PCLO as antigenic target; single cohort study","pmids":["39892202"],"is_preprint":false}],"current_model":"PCLO encodes Piccolo, a presynaptic active zone scaffolding protein with calcium-sensing (C2) and PDZ domains that regulates presynaptic vesicle organization and neurotransmitter release; it also functions in astrocytes via a Golgi-associated isoform to control ECM (Brevican/Tenascin-R) secretion required for synaptogenesis, and loss-of-function mutations cause pontocerebellar hypoplasia type III through disruption of these neuronal and glial mechanisms."},"narrative":{"teleology":[{"year":2002,"claim":"Cloning and comparative sequence analysis established PCLO as the gene encoding the presynaptic active zone protein Piccolo and defined its multi-domain architecture, revealing shared but distinct homology with Bassoon.","evidence":"cDNA cloning and comparative sequence analysis across human, mouse, rat, and chicken","pmids":["12175852"],"confidence":"Medium","gaps":["Domain-level functions (PDZ, C2) were inferred by homology, not experimentally validated","No functional assays for neurotransmitter release were performed","Relationship to Bassoon at the functional level remained undefined"]},{"year":2013,"claim":"A deep intronic PCLO SNP was shown to directly regulate splicing efficiency, demonstrating that non-coding variation within PCLO can alter transcript processing and potentially protein isoform ratios.","evidence":"Functional minigene splicing assay combined with bioinformatic prediction of splicing regulatory motifs","pmids":["24167553"],"confidence":"Medium","gaps":["Effect on endogenous PCLO transcript levels or isoform ratios in brain tissue was not measured","Downstream functional consequence of altered splicing on Piccolo protein or synaptic function was not assessed"]},{"year":2015,"claim":"A human loss-of-function mutation eliminating the PDZ and C2 domains was shown to cause PCH3, establishing that Piccolo is essential for cerebellar and pontine neuronal development and survival.","evidence":"Whole-exome sequencing with linkage analysis in an affected family, supported by fetal brain RNA-seq","pmids":["25832664"],"confidence":"Medium","gaps":["Single family study; independent replication in additional kindreds was not available at the time","Cellular mechanism by which C-terminal domain loss leads to neurodegeneration was not elucidated","Whether PCH3 involves glial as well as neuronal dysfunction was unknown"]},{"year":2015,"claim":"A knock-in variant near the Piccolo C2 domain was shown to increase synaptic protein levels and enhance excitatory transmission, establishing that Piccolo abundance at the synapse directly modulates neurotransmitter release strength.","evidence":"Mouse Pclo SA/SA knock-in with electrophysiology, immunostaining, and calcium-dependent phospholipid binding assay in cultured neurons","pmids":["26045179"],"confidence":"High","gaps":["Mechanism by which a single amino acid change increases Piccolo protein levels (stability vs. trafficking) was not determined","In vivo circuit-level consequences of enhanced excitatory transmission were not assessed"]},{"year":2025,"claim":"A second PCH3-causing PCLO mutation (p.Met153Thr) was identified and validated in a CRISPR knockout model, confirming the disease gene relationship and revealing that Piccolo deficiency dysregulates Bassoon and CtBP1 expression, pointing to a broader scaffolding network disruption.","evidence":"Whole-exome sequencing, CRISPR PCLO knockout cell model, real-time PCR","pmids":["42038819"],"confidence":"Medium","gaps":["Whether CtBP1 and Bassoon changes are direct or indirect consequences of Piccolo loss is unclear","Neuronal or cerebellar phenotype of the Met153Thr variant was not modeled in vivo"]},{"year":2025,"claim":"Discovery of an astrocyte-specific Piccolo isoform at the Golgi revealed a non-neuronal function: maintaining Golgi integrity, enabling ECM secretion (Brevican, Tenascin-R), and supporting synaptogenesis, thereby expanding Piccolo's role beyond presynaptic scaffolding to glial-mediated synapse regulation.","evidence":"(preprint) Pclo gene-trap rat model with RNA-seq, Golgi morphology analysis, astrocyte-conditioned media rescue, co-culture synapse density assays, and electrophysiology","pmids":["bio_10.1101_2025.07.03.662734"],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed","Whether astrocytic Piccolo dysfunction contributes to PCH3 pathology in patients is untested","Molecular mechanism by which Piccolo maintains Golgi integrity is undefined"]},{"year":null,"claim":"The precise molecular mechanisms by which Piccolo organizes the active zone scaffold, maintains Golgi structure, and how its loss leads selectively to pontocerebellar neurodegeneration remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structural model of Piccolo domains in complex with active zone partners exists","The relative contributions of neuronal versus astrocytic Piccolo loss to PCH3 pathogenesis are unknown","Whether Piccolo's role in ECM secretion extends to in vivo brain development has not been shown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[4]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,1,2]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,5]}],"complexes":[],"partners":["BSN","CTBP1","BCAN","TNC"],"other_free_text":[]},"mechanistic_narrative":"PCLO encodes Piccolo, a large presynaptic cytoskeletal scaffolding protein that organizes active zones to regulate neurotransmitter release, sharing partial domain homology with Bassoon [PMID:12175852]. Piccolo contains PDZ and C2 calcium-sensing domains in its C-terminus; a knock-in variant near the C2 domain increases synaptic Piccolo levels and enhances excitatory transmission by ~30% [PMID:26045179], while loss-of-function mutations that eliminate these domains cause autosomal recessive pontocerebellar hypoplasia type III (PCH3), and Piccolo deficiency alters expression of interacting partners Bassoon and CtBP1 [PMID:25832664, PMID:42038819]. In astrocytes, a distinct Piccolo isoform partially localizes to the Golgi apparatus, where it maintains Golgi integrity and is required for secretion of the extracellular matrix components Brevican and Tenascin-R; loss of astrocytic Piccolo reduces synapse density and alters neuronal network activity, deficits rescued by wild-type astrocyte-conditioned media [PMID:bio_10.1101_2025.07.03.662734]."},"prefetch_data":{"uniprot":{"accession":"Q9Y6V0","full_name":"Protein piccolo","aliases":["Aczonin"],"length_aa":5142,"mass_kda":560.7,"function":"Scaffold protein of the presynaptic cytomatrix at the active zone (CAZ) which is the place in the synapse where neurotransmitter is released (By similarity). After synthesis, participates in the formation of Golgi-derived membranous organelles termed Piccolo-Bassoon transport vesicles (PTVs) that are transported along axons to sites of nascent synaptic contacts (By similarity). At the presynaptic active zone, regulates the spatial organization of synaptic vesicle cluster, the protein complexes that execute membrane fusion and compensatory endocytosis (By similarity). Organizes as well the readily releasable pool of synaptic vesicles and safeguards a fraction of them to be not immediately available for action potential-induced release (By similarity). Also functions in processes other than assembly such as the regulation of specific presynaptic protein ubiquitination by interacting with SIAH1 or the regulation of presynaptic autophagy (By similarity). Also mediates synapse to nucleus communication leading to reconfiguration of gene expression by associating with the transcriptional corepressor CTBP1 and by subsequently reducing the size of its pool available for nuclear import (By similarity)","subcellular_location":"Presynaptic active zone","url":"https://www.uniprot.org/uniprotkb/Q9Y6V0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PCLO","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PCLO","total_profiled":1310},"omim":[{"mim_id":"617250","title":"ELKS/RAB6-INTERACTING/CAST FAMILY, MEMBER 2; ERC2","url":"https://www.omim.org/entry/617250"},{"mim_id":"609894","title":"UNC13 HOMOLOG A; UNC13A","url":"https://www.omim.org/entry/609894"},{"mim_id":"608027","title":"PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3","url":"https://www.omim.org/entry/608027"},{"mim_id":"607596","title":"PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A","url":"https://www.omim.org/entry/607596"},{"mim_id":"606629","title":"PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 1; RIMS1","url":"https://www.omim.org/entry/606629"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Nuclear speckles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":21.2},{"tissue":"retina","ntpm":20.1}],"url":"https://www.proteinatlas.org/search/PCLO"},"hgnc":{"alias_symbol":["KIAA0559","DKFZp779G1236","ACZ"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y6V0","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y6V0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y6V0-3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y6V0-3-F1-predicted_aligned_error_v6.png","plddt_mean":66.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PCLO","jax_strain_url":"https://www.jax.org/strain/search?query=PCLO"},"sequence":{"accession":"Q9Y6V0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y6V0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y6V0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y6V0"}},"corpus_meta":[{"pmid":"24167553","id":"PMC_24167553","title":"Functional analysis of deep intronic SNP rs13438494 in intron 24 of PCLO gene.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24167553","citation_count":50,"is_preprint":false},{"pmid":"25832664","id":"PMC_25832664","title":"Loss of PCLO function underlies pontocerebellar hypoplasia type III.","date":"2015","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25832664","citation_count":47,"is_preprint":false},{"pmid":"19942622","id":"PMC_19942622","title":"The PCLO gene and depressive disorders: replication in a population-based study.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19942622","citation_count":38,"is_preprint":false},{"pmid":"12175852","id":"PMC_12175852","title":"Gene structure and genetic localization of the PCLO gene encoding the presynaptic active zone protein Piccolo.","date":"2002","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12175852","citation_count":31,"is_preprint":false},{"pmid":"28540843","id":"PMC_28540843","title":"Genome-Wide Significance for PCLO as a Gene for Major Depressive Disorder.","date":"2017","source":"Twin research and human genetics : the official journal of the International Society for Twin Studies","url":"https://pubmed.ncbi.nlm.nih.gov/28540843","citation_count":22,"is_preprint":false},{"pmid":"34834409","id":"PMC_34834409","title":"Identification of Rare Mutations of Two Presynaptic Cytomatrix Genes BSN and PCLO in Schizophrenia and Bipolar Disorder.","date":"2021","source":"Journal of personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34834409","citation_count":19,"is_preprint":false},{"pmid":"22386049","id":"PMC_22386049","title":"PCLO gene: its role in vulnerability to major depressive disorder.","date":"2012","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/22386049","citation_count":19,"is_preprint":false},{"pmid":"18647954","id":"PMC_18647954","title":"PCLO variants are nominally associated with early-onset type 2 diabetes and insulin resistance in Pima Indians.","date":"2008","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/18647954","citation_count":16,"is_preprint":false},{"pmid":"28556829","id":"PMC_28556829","title":"PCLO rs2522833-mediated gray matter volume reduction in patients with drug-naive, first-episode major depressive disorder.","date":"2017","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/28556829","citation_count":16,"is_preprint":false},{"pmid":"20701824","id":"PMC_20701824","title":"PCLO rs2522833 modulates HPA system response to antidepressant treatment in major depressive disorder.","date":"2010","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20701824","citation_count":12,"is_preprint":false},{"pmid":"22832399","id":"PMC_22832399","title":"PCLO rs2522833 impacts HPA system activity in healthy young adults.","date":"2011","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22832399","citation_count":10,"is_preprint":false},{"pmid":"26045179","id":"PMC_26045179","title":"Functional characterization of the PCLO p.Ser4814Ala variant associated with major depressive disorder reveals cellular but not behavioral differences.","date":"2015","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26045179","citation_count":9,"is_preprint":false},{"pmid":"35328053","id":"PMC_35328053","title":"Characterization of PCLO Gene in Amazonian Native American Populations.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35328053","citation_count":6,"is_preprint":false},{"pmid":"37598873","id":"PMC_37598873","title":"Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle.","date":"2023","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/37598873","citation_count":5,"is_preprint":false},{"pmid":"37935138","id":"PMC_37935138","title":"Exploration of the Tumour Biological Significance of PCLO in Gastric Cancer: Results from a Large Central European Cohort.","date":"2023","source":"Pathobiology : journal of immunopathology, molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/37935138","citation_count":5,"is_preprint":false},{"pmid":"23862039","id":"PMC_23862039","title":"Implications of a Chr7q21.11 Microdeletion and the Role of the PCLO Gene in Developmental Delay.","date":"2013","source":"Sultan Qaboos University medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/23862039","citation_count":3,"is_preprint":false},{"pmid":"40699825","id":"PMC_40699825","title":"PCLO Is Associated with Tumor Mutational Burden and Immunity in Patients with Oral Squamous Cell Carcinoma.","date":"2025","source":"Current issues in molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/40699825","citation_count":1,"is_preprint":false},{"pmid":"25379724","id":"PMC_25379724","title":"No evidence for the association between a polymorphism in the PCLO depression candidate gene with memory bias in remitted depressed patients and healthy individuals.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25379724","citation_count":1,"is_preprint":false},{"pmid":"40661989","id":"PMC_40661989","title":"Pontocerebellar Hypoplasia Type 3 With Two Novel PCLO Gene Mutations: A Case Report.","date":"2025","source":"Case reports in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/40661989","citation_count":1,"is_preprint":false},{"pmid":"39892202","id":"PMC_39892202","title":"Anti-retinal immune response in sarcoid uveitis: A potential role for PCLO as an antigenic target.","date":"2025","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/39892202","citation_count":0,"is_preprint":false},{"pmid":"42038819","id":"PMC_42038819","title":"Novel Insights into Pontocerebellar Hypoplasia Type 3: Discovery of a New Disease-causing PCLO Variant and Development of a CRISPR-generated Cell Model : Novel Insights into Pontocerebellar Hypoplasia Type 3.","date":"2025","source":"Galen medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/42038819","citation_count":0,"is_preprint":false},{"pmid":"11550907","id":"PMC_11550907","title":"Genetic and molecular characterization of a variegating hsp70-acZ fusion gene in the euchromatic 31 B region of Drosophila melanogaster.","date":"2001","source":"Genome","url":"https://pubmed.ncbi.nlm.nih.gov/11550907","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.01.21.634055","title":"Modeling Synaptic Maturation from Growth Cone to Synapse in Human Organoids","date":"2025-01-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.21.634055","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.03.662734","title":"Piccolo Regulates Secretion of the Extracellular Matrix Components Brevican and Tenascin R from Astrocytes to Drive Synapse Formation: Implications for Pontocerebellar Hypoplasia Type 3 (PCH3)","date":"2025-07-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.03.662734","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.18.25329418","title":"Imputation of fluid intelligence scores reduces ascertainment bias and increases power for analyses of common and rare variants","date":"2025-06-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.18.25329418","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.09.24315081","title":"A novel model to quantify blood transit time in cerebral arteries using ASL-based 4D magnetic resonance angiography with example clinical application in moyamoya disease","date":"2024-10-11","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.09.24315081","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.05.24.595729","title":"Molecular Specializations Underlying Phenotypic Differences in Inner Ear Hair Cells of Zebrafish and Mice","date":"2024-05-26","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.24.595729","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14679,"output_tokens":1755,"usd":0.035181},"stage2":{"model":"claude-opus-4-6","input_tokens":5009,"output_tokens":1954,"usd":0.110842},"total_usd":0.146023,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"PCLO encodes the presynaptic cytoskeletal protein Piccolo, which is a component of presynaptic active zones involved in assembly and function of active zones as sites of neurotransmitter release; comparative sequence analysis identified distinct homology domains shared partially with Bassoon, indicating related but distinct functions at active zones.\",\n      \"method\": \"cDNA cloning, comparative sequence analysis, chromosomal localization, gene structure characterization across human, mouse, rat, and chicken\",\n      \"journal\": \"International journal of developmental neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gene structure and domain architecture established by direct molecular characterization; single lab, multiple species comparison\",\n      \"pmids\": [\"12175852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The PCLO p.Ser4814Ala (rs2522833) variant, located near a calcium-sensing domain of Piccolo, increases synaptic Piccolo protein levels and produces ~30% increased excitatory synaptic transmission in cultured neurons; calcium-dependent phospholipid binding, synapse formation in vitro, and synaptic vesicle accumulation were unaltered by this variant.\",\n      \"method\": \"Mouse knock-in model (Pclo SA/SA), electrophysiology in cultured neurons, calcium-dependent phospholipid binding assay, immunostaining for synaptic protein levels\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo knock-in model combined with multiple orthogonal cellular assays (electrophysiology, binding assay, immunostaining)\",\n      \"pmids\": [\"26045179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Homozygous nonsense mutation in PCLO (predicted to eliminate the PDZ and C2 domains in the C-terminus) causes loss of Piccolo protein function and underlies autosomal recessive pontocerebellar hypoplasia type III (PCH3), establishing that PCLO is essential for development and survival of neuronal types in the human brain.\",\n      \"method\": \"Whole-exome sequencing, Sanger sequencing, linkage analysis, human fetal brain RNA sequencing\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — segregating loss-of-function variant with defined neurological phenotype; single family but supported by domain-level prediction\",\n      \"pmids\": [\"25832664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The deep intronic SNP rs13438494 in intron 24 of PCLO alters splicing efficiency by creating or disrupting splicing regulatory motifs (enhancer/silencer binding sites), with the C allele reducing splicing efficiency of the PCLO minigene.\",\n      \"method\": \"Functional minigene splicing assay, bioinformatics prediction of splicing regulatory sequences (Human Splice Finder)\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct minigene functional assay demonstrating altered splicing; single lab with functional validation\",\n      \"pmids\": [\"24167553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Piccolo is expressed as a novel astrocyte-specific isoform that partially localizes at the Golgi apparatus; loss of Piccolo function in astrocytes (Pclo gt/gt rat model) causes fragmented Golgi morphology and impaired secretion of extracellular matrix components Brevican and Tenascin-R, leading to reduced synapse density in co-cultured neurons and altered network activity, deficits rescued by wild-type astrocyte conditioned media.\",\n      \"method\": \"Pclo gene-trap rat model, RNA-sequencing, immunohistochemistry/immunocytochemistry, GM130 Golgi staining, astrocyte-conditioned media rescue experiments, electrophysiology (mEPSC, mIPSC, RRP), co-culture synapse density assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in a genetic model with functional rescue; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.07.03.662734\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A novel homozygous missense variant in PCLO (p.Met153Thr) causes PCH3; CRISPR-generated PCLO knockout cell model confirmed loss of Piccolo protein function and showed that Piccolo deficiency affects expression of interacting genes CtBP1 and BSN (Bassoon).\",\n      \"method\": \"Whole-exome sequencing, CRISPR knockout cell model, real-time PCR, in silico pathogenicity analysis\",\n      \"journal\": \"Galen medical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR loss-of-function model with molecular readouts; single lab\",\n      \"pmids\": [\"42038819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PCLO protein (Piccolo) was identified as an autoimmune antigenic target in sarcoid uveitis: anti-PCLO autoantibodies (humoral response) and PCLO-reactive T-lymphocytes (cellular response) were detected in anti-retinal antibody-positive sarcoid uveitis patients.\",\n      \"method\": \"HuScan linear epitope autoantibody profiling, bead-based anti-PCLO antibody assay, ELISpot for PCLO-reactive T-lymphocytes, indirect immunofluorescence, TCR/BCR next-generation sequencing\",\n      \"journal\": \"Journal of autoimmunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal immunological assays identifying PCLO as antigenic target; single cohort study\",\n      \"pmids\": [\"39892202\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PCLO encodes Piccolo, a presynaptic active zone scaffolding protein with calcium-sensing (C2) and PDZ domains that regulates presynaptic vesicle organization and neurotransmitter release; it also functions in astrocytes via a Golgi-associated isoform to control ECM (Brevican/Tenascin-R) secretion required for synaptogenesis, and loss-of-function mutations cause pontocerebellar hypoplasia type III through disruption of these neuronal and glial mechanisms.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PCLO encodes Piccolo, a large presynaptic cytoskeletal scaffolding protein that organizes active zones to regulate neurotransmitter release, sharing partial domain homology with Bassoon [PMID:12175852]. Piccolo contains PDZ and C2 calcium-sensing domains in its C-terminus; a knock-in variant near the C2 domain increases synaptic Piccolo levels and enhances excitatory transmission by ~30% [PMID:26045179], while loss-of-function mutations that eliminate these domains cause autosomal recessive pontocerebellar hypoplasia type III (PCH3), and Piccolo deficiency alters expression of interacting partners Bassoon and CtBP1 [PMID:25832664, PMID:42038819]. In astrocytes, a distinct Piccolo isoform partially localizes to the Golgi apparatus, where it maintains Golgi integrity and is required for secretion of the extracellular matrix components Brevican and Tenascin-R; loss of astrocytic Piccolo reduces synapse density and alters neuronal network activity, deficits rescued by wild-type astrocyte-conditioned media [PMID:bio_10.1101_2025.07.03.662734].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Cloning and comparative sequence analysis established PCLO as the gene encoding the presynaptic active zone protein Piccolo and defined its multi-domain architecture, revealing shared but distinct homology with Bassoon.\",\n      \"evidence\": \"cDNA cloning and comparative sequence analysis across human, mouse, rat, and chicken\",\n      \"pmids\": [\"12175852\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Domain-level functions (PDZ, C2) were inferred by homology, not experimentally validated\",\n        \"No functional assays for neurotransmitter release were performed\",\n        \"Relationship to Bassoon at the functional level remained undefined\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"A deep intronic PCLO SNP was shown to directly regulate splicing efficiency, demonstrating that non-coding variation within PCLO can alter transcript processing and potentially protein isoform ratios.\",\n      \"evidence\": \"Functional minigene splicing assay combined with bioinformatic prediction of splicing regulatory motifs\",\n      \"pmids\": [\"24167553\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Effect on endogenous PCLO transcript levels or isoform ratios in brain tissue was not measured\",\n        \"Downstream functional consequence of altered splicing on Piccolo protein or synaptic function was not assessed\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A human loss-of-function mutation eliminating the PDZ and C2 domains was shown to cause PCH3, establishing that Piccolo is essential for cerebellar and pontine neuronal development and survival.\",\n      \"evidence\": \"Whole-exome sequencing with linkage analysis in an affected family, supported by fetal brain RNA-seq\",\n      \"pmids\": [\"25832664\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single family study; independent replication in additional kindreds was not available at the time\",\n        \"Cellular mechanism by which C-terminal domain loss leads to neurodegeneration was not elucidated\",\n        \"Whether PCH3 involves glial as well as neuronal dysfunction was unknown\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A knock-in variant near the Piccolo C2 domain was shown to increase synaptic protein levels and enhance excitatory transmission, establishing that Piccolo abundance at the synapse directly modulates neurotransmitter release strength.\",\n      \"evidence\": \"Mouse Pclo SA/SA knock-in with electrophysiology, immunostaining, and calcium-dependent phospholipid binding assay in cultured neurons\",\n      \"pmids\": [\"26045179\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which a single amino acid change increases Piccolo protein levels (stability vs. trafficking) was not determined\",\n        \"In vivo circuit-level consequences of enhanced excitatory transmission were not assessed\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A second PCH3-causing PCLO mutation (p.Met153Thr) was identified and validated in a CRISPR knockout model, confirming the disease gene relationship and revealing that Piccolo deficiency dysregulates Bassoon and CtBP1 expression, pointing to a broader scaffolding network disruption.\",\n      \"evidence\": \"Whole-exome sequencing, CRISPR PCLO knockout cell model, real-time PCR\",\n      \"pmids\": [\"42038819\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether CtBP1 and Bassoon changes are direct or indirect consequences of Piccolo loss is unclear\",\n        \"Neuronal or cerebellar phenotype of the Met153Thr variant was not modeled in vivo\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery of an astrocyte-specific Piccolo isoform at the Golgi revealed a non-neuronal function: maintaining Golgi integrity, enabling ECM secretion (Brevican, Tenascin-R), and supporting synaptogenesis, thereby expanding Piccolo's role beyond presynaptic scaffolding to glial-mediated synapse regulation.\",\n      \"evidence\": \"(preprint) Pclo gene-trap rat model with RNA-seq, Golgi morphology analysis, astrocyte-conditioned media rescue, co-culture synapse density assays, and electrophysiology\",\n      \"pmids\": [\"bio_10.1101_2025.07.03.662734\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Preprint not yet peer-reviewed\",\n        \"Whether astrocytic Piccolo dysfunction contributes to PCH3 pathology in patients is untested\",\n        \"Molecular mechanism by which Piccolo maintains Golgi integrity is undefined\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The precise molecular mechanisms by which Piccolo organizes the active zone scaffold, maintains Golgi structure, and how its loss leads selectively to pontocerebellar neurodegeneration remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structural model of Piccolo domains in complex with active zone partners exists\",\n        \"The relative contributions of neuronal versus astrocytic Piccolo loss to PCH3 pathogenesis are unknown\",\n        \"Whether Piccolo's role in ECM secretion extends to in vivo brain development has not been shown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"BSN\",\n      \"CTBP1\",\n      \"BCAN\",\n      \"TNC\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}